PharmEasy's $5.6 billion value shrinks to $456 million, investor data shows | TechCrunchPharmEasy's valuation has dropped 92% to $456 million, highlighting significant challenges in its financial strategy and market conditions.
PharmEasy still 92% below its peak $5.6 billion valuation, investor estimates | TechCrunchPharmEasy's current valuation is $458 million, down 92% from its peak of $5.6 billion, highlighting significant market challenges.
PharmEasy's $5.6 billion value shrinks to $456 million, investor data shows | TechCrunchPharmEasy's valuation has dropped 92% to $456 million, highlighting significant challenges in its financial strategy and market conditions.
PharmEasy still 92% below its peak $5.6 billion valuation, investor estimates | TechCrunchPharmEasy's current valuation is $458 million, down 92% from its peak of $5.6 billion, highlighting significant market challenges.